Literature DB >> 12464590

Changes in breast cancer therapy because of pathology second opinions.

Valerie L Staradub1, Kathleen A Messenger, Nanjiang Hao, Elizabeth L Wiley, Monica Morrow.   

Abstract

BACKGROUND: Examination of pathology slides is a routine part of a breast cancer second opinion. The purpose of this study was to determine how often the pathologic second opinion (1) altered the diagnosis and (2) resulted in a change in the surgical procedure.
METHODS: Patients presenting between 1997 and 2001 for a second opinion after a biopsy diagnosis of breast cancer (invasive or noninvasive) were included in this study.
RESULTS: There were 340 patients presenting for second opinions regarding 346 breast cancers. Sixty-eight pathologic second opinions (20%) did not result in any change in pathology or prognostic factors, whereas in the remaining 80%, some change occurred. Major changes that altered surgical therapy occurred in 7.8% of cases, and pathology review provided additional prognostic information in 40%. Changes were more common in in situ carcinoma than invasive carcinoma (P =.004), but biopsy type (core vs. excisional biopsy) was not a significant predictor of change in pathologic information.
CONCLUSIONS: This study confirms the benefit of a pathology second opinion to improve preoperative estimates of prognosis and to determine the appropriate surgical procedure. Missing information on grade and histological subtype was responsible for a large number of cases, suggesting a need for widespread application of standardization and quality improvement in pathology reporting.

Entities:  

Mesh:

Year:  2002        PMID: 12464590     DOI: 10.1007/bf02574516

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

1.  [Testicular germ cell cancer : interdependence between guidelines and a second-opinion system].

Authors:  M Schrader; M Hartmann; S Krege; A Heidenreich; K Miller; L Weissbach
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

2.  Imaging mass spectrometry: a new tool for pathology in a molecular age.

Authors:  Jeremy L Norris; Richard M Caprioli
Journal:  Proteomics Clin Appl       Date:  2013-12       Impact factor: 3.494

3.  Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.

Authors:  Brian Shuch; Jonathan N Hofmann; Maria J Merino; Jeffrey W Nix; Srinivas Vourganti; W Marston Linehan; Kendra Schwartz; Julie J Ruterbusch; Joanne S Colt; Mark P Purdue; Wong-Ho Chow
Journal:  Urol Oncol       Date:  2013-02-28       Impact factor: 3.498

Review 4.  How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?

Authors:  Habib Rahbar; Elizabeth S McDonald; Janie M Lee; Savannah C Partridge; Christoph I Lee
Journal:  Acad Radiol       Date:  2016-03-23       Impact factor: 3.173

5.  Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.

Authors:  Eileen Rakovitch; Sharon Nofech-Mozes; Wedad Hanna; Rinku Sutradhar; Frederick L Baehner; Dave P Miller; Cindy Fong; Sumei Gu; Alan Tuck; Sandip Sengupta; Leela Elavathil; Prashant A Jani; Michel Bonin; Martin C Chang; Elzbieta Slodkowska; Joseph M Anderson; Diana B Cherbavaz; Steven Shak; Lawrence Paszat
Journal:  J Natl Cancer Inst       Date:  2017-04-01       Impact factor: 13.506

Review 6.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

7.  The Influence of Radiology Image Consultation in the Surgical Management of Breast Cancer Patients.

Authors:  Melissa Anne Mallory; Katya Losk; Nancy U Lin; Yasuaki Sagara; Robyn L Birdwell; Linda Cutone; Kristen Camuso; Craig Bunnell; Fatih Aydogan; Mehra Golshan
Journal:  Ann Surg Oncol       Date:  2015-07-23       Impact factor: 5.344

8.  Inter-institutional pathology consultations for breast cancer: impact on clinical oncology therapy recommendations.

Authors:  J A Price; E Grunfeld; P J Barnes; D E Rheaume; D Rayson
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

9.  Second opinion in breast pathology: policy, practice and perception.

Authors:  Berta M Geller; Heidi D Nelson; Patricia A Carney; Donald L Weaver; Tracy Onega; Kimberly H Allison; Paul D Frederick; Anna N A Tosteson; Joann G Elmore
Journal:  J Clin Pathol       Date:  2014-07-22       Impact factor: 3.411

10.  Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center.

Authors:  Mehra Golshan; Katya Losk; Melissa A Mallory; Kristen Camuso; Susan Troyan; Nancy U Lin; Sarah Kadish; Craig A Bunnell
Journal:  Ann Surg Oncol       Date:  2015-08-26       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.